News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News TCT 2024 Embolic Protection Benefits Varied by Geography in PROTECTED TAVR Todd Neale October 31, 2024
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
Presentation ESC 2024 OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation Presenter: Manesh R. Patel September 01, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Conference News NY Valves 2024 Leaks After LAAO Do Matter, Experts Agree Todd Neale June 10, 2024
News Conference News ESOC 2024 Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60 Todd Neale May 17, 2024
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Daily News Potential Contributors to ESUS Explored in New Consensus Statement Todd Neale May 14, 2024
News Conference News EHRA 2024 Stroke Rates Fall Among AF Patients Not on Anticoagulation Todd Neale April 11, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News ISC 2024 AI-Based System Boosts Quality of Stroke Care and Reduces Events Todd Neale February 16, 2024
News Conference News ISC 2024 Speedier Anticoagulation Reversal Tied to Better ICH Outcomes Todd Neale February 15, 2024